A rise in inflammatory markers, such as interleukin 6 (IL-6) and C-reactive protein (CRP), are potent predictors of impaired kidney function and the development of cardiovascular disease in CKD patients [8,9]. This evidence concerns the gene CRP and chronic kidney disease.